Aaro J. Jalkanen - Concepedia

Author

Aaro J. Jalkanen

University of Eastern Finland ORCID

Also Known As

A. Jalkanen, Aaro J Jalkanen, Aaro J. Jalkanen, Aaro Jalkanen

Publications

737

Citations

H-Index

Concepts

All Affiliations

University of Eastern Finland University of Helsinki Finland University

About

Aaro J. Jalkanen is an author at University of Eastern Finland specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	329
2	Biochemistry	4	4	141
3	Social Sciences	3	3	107
4	Cell Biology	3	3	73
5	Immunology	1	1	42

Aaro J. Jalkanen

Publications

568

Citations

H-Index

Page 1

	Year	Citations
Brain uptake of ketoprofen–lysine prodrug in rats Mikko Gynther, Aaro J. Jalkanen, Marko Lehtonen, International Journal of Pharmaceutics NeurophysiologyMedicineNeuropharmacologyNeuroprotectionPharmacotherapy	2010	76
Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors Jarkko I. Venäläinen, J. Arturo García‐Horsman, Markus Forsberg, Biochemical Pharmacology BiochemistryMedicineGlycobiologyMechanism Of ActionVivo Action	2006	69
Comparison of in vitro cell models in predicting in vivo brain entry of drugs Jenni J. Hakkarainen, Aaro J. Jalkanen, Tiina M. Kääriäinen, International Journal of Pharmaceutics Pharmacokinetic ModelingPreclinical Drug EvaluationComputational NeuroscienceVitro Cell ModelsMedicine	2010	58
L-Type Amino Acid Transporter 1 Enables the Efficient Brain Delivery of Small-Sized Prodrug across the Blood–Brain Barrier and into Human and Mouse Brain Parenchymal Cells Ahmed B. Montaser, Juulia Järvinen, Susanne Löffler, ACS Chemical Neuroscience	2020	58
Beneficial Effect of Prolyl Oligopeptidase Inhibition on Spatial Memory in Young but Not in Old Scopolamine‐Treated Rats Aaro J. Jalkanen, Katja A. Puttonen, Jarkko I. Venäläinen, Basic & Clinical Pharmacology & Toxicology	2006	44
Extracellular prolyl oligopeptidase derived from activated microglia is a potential neuroprotection target Teemu Natunen, Mikko Gynther, Hannah Rostalski, Basic & Clinical Pharmacology & Toxicology NeuropeptidesImmunologyImmune RegulationCell DeathExtracellular Prolyl Oligopeptidase	2018	42
Brain Pharmacokinetics of Two Prolyl Oligopeptidase Inhibitors, JTP-4819 and KYP-2047, in the Rat Aaro J. Jalkanen, Jenni J. Hakkarainen, Marko Lehtonen, Basic & Clinical Pharmacology & Toxicology	2011	32
The effect of prolyl oligopeptidase inhibition on extracellular acetylcholine and dopamine levels in the rat striatum Aaro J. Jalkanen, Petteri Piepponen, Jenni J. Hakkarainen, Neurochemistry International Extracellular AcetylcholineBiochemistryNeurophysiologyMedicineNeuropeptide Receptor	2011	30
Brief isoflurane anesthesia regulates striatal AKT‐GSK3β signaling and ameliorates motor deficits in a rat model of early‐stage Parkinson′s disease Juuso V. Leikas, Samuel Kohtala, Wiebke Theilmann, Journal of Neurochemistry	2017	27
Inhibition of prolyl oligopeptidase by KYP-2047 fails to increase the extracellular neurotensin and substance P levels in rat striatum Aaro J. Jalkanen, Katja Savolainen, Markus Forsberg Neuroscience Letters NeuropeptidesBiochemistryMedicinePhysiologyNeuropeptide Receptor	2011	23

Page 1